20663 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Microorganisms or materials therefrom Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
COMPOSITIONS AND METHODS TO IMPROVE SEQUESTRATION OF MYCOTOXINS AND THEIR USE IN DETOXIFICATION OF ANIMAL FEED AND ANIMAL PRODUCTION SYSTEMS
#2ENGINEERED PARASITES FOR DELIVERING PROTEIN TO THE CENTRAL NERVOUS SYSTEM (CNS)
#3COMPOSITIONS HAVING HIGH LEVELS OF DPA (n-3) AND METHODS FOR PRODUCING
#4FULL LIGHT REPAIR
#5NATURAL WATER-SOLUBLE PLANT COMPOUND WITH ANTIDEPRESSANT AND SLEEP-PROMOTING EFFECTS, AND PREPARATION METHOD AND USE THEREOF
#6USE OF PLASMODIUM IN PREPARATION OF ANTI-TUMOR PREPARATION FOR USE IN COMBINATION WITH RADIOTHERAPY
#7USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION
#8Natural non-pathogenic microorganisms capable of associating glycolipids or lipopeptides and use thereof
#9CHANNELED FIBERS IN SEPARATION OF BIOLOGICALLY ACTIVE NANOPARTICLES
#10DRUG FOR PREVENTING AND/OR TREATING BRAIN TUMOR AND APPLICATION THEREOF
#11REDUCING OXYGEN LEVELS IN THE GASTROINTESTINAL TRACT
#12Compositions and Methods for Increasing Epithelial Barrier Function
#13TOXOPLASMA PLATFORM FOR TREATING CANCER
#14USE OF PARASITES AND EXTRACELLULAR VESICLES OBTAINED FROM PARASITES IN CANCER TREATMENT
#15Engineered parasites for delivering protein to the central nervous system (CNS)
#16EICOSAPENTAENOIC ACID-PRODUCING MICROORGANISMS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF
#17Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine
#18Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation
#19Antibiotic-free compositions for the prevention or control of coccidiosis
#20ANTI-BIOFILM AGENTS AND USES THEREOF
#21METHODS OF TREATING AN AUTOIMMUNE DISEASE
#22METHODS AND COMPOSITIONS FOR THE TREATMENT OF RADIATION-RELATED DISORDERS
#23Preparation of flagellin vaccine adjuvant-based vaccine to induce production of antibody recognizing conformation of antigens, and application thereof
#24Mucosal adjuvants and delivery systems
#25Therapeutic or non-therapeutic use of protozoans of the genus as a fungistatic and/or fungicide
#26NEOSPORA FOR USE IN TREATING CANCER AND INFECTIOUS DISEASES
#27Composition, A Treatment Method and An Application Thereof
#28Rabbit coccidiosis vaccine and application thereof
#29Live attenuated parasitic vaccine
#30Engineered parasites for delivering protein to the central nervous system (CNS)
#31Antibiotic-free compositions for the prevention or control of coccidiosis
#32Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine
#33Channeled fibers in separation of biologically active nanoparticles
#34Amoeba therapeutic dressings, biomaterials, and solutions
#35Methods and compositions for the treatment of radiation-related disorders
#36ANTIVIRAL AGENT AND ANTIVIRAL FOOD
#37CROSS-REGULATION OF TYPE I INTERFERON SIGNALING PATHWAYS
#38A Composition, A Treatment Method and An Application Thereof
#39for use in treating cancer and infectious diseases
#40Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation
#41Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#42METHOD OF PROMOTING IMMUNE HEALTH USING THE WATER-SOLUBLE COMPONENT FROM GENUS EUGLENA ORGANISM
#43Suppressive agent for rheumatoid arthritis, prophylactic agent for rheumatoid arthritis, therapeutic agent for rheumatoid arthritis, and food for suppressing rheumatoid arthritis
#44Mosquito saliva protein malaria vaccine
#45Prophylactic or therapeutic agent for peptic ulcer, food additive for prophylactic or therapeutic use, iNOS expression inhibitor and COX-2 expression inhibitor
#46Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#47USE OF ATTENUATED PARASITE STRAINS FOR THE PREVENTION AND/OR TREATMENT OF EYE WOUNDS ASSOCIATED WITH AN INFECTION BY TOXOPLASMA GONDII
#48Therapeutic compositions and methods for treating infections
#49Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#50Targeting of chondroitin sulfate glycans
#51DICTYOSTELID AMOEBA AND BIOCONTROL USES THEREOF
#52Therapeutic amoeba and uses thereof
#53Means of inducing cellular exocytosis and uses thereof
#54T. CRUZI-DERIVED NEUROTROPHIC AGENTS AND METHODS OF USE THEREFOR
#55USE OF TOXOPLASMA AND DERIVED COMPOSITIONS TO PREVENT OR TREAT MICROBIAL INFECTIONS
#56Modified protozoan expressing at least two variable surface proteins (VSP), a vaccine comprising it and procedures, uses, and methods thereof
#57PHARMACEUTICAL COMPOSITION, DRUG SCREENING METHOD AND METHOD FOR TREATING MALARIA
#58Therapeutic amoeba and uses thereof
#59Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#60INACTIVATION OF GENES OF THE MEP PATHWAY
#61USE OF A NEW ISOLATE OF NEOSPORA CANINUM FOR THE DEVELOPMENT OF DIAGNOSTIC TESTS AND FOR PREPARATION OF PRODUCTS FOR TREATMENT AND PREVENTION OF THE INFECTION CAUSED BY NEOSPORA
#62Use of coccidian
#63PROCESS TO ACTIVATE EXTRACTS DERIVED FROM LIVING ORGANISMS USING LONG WAVE UV IRRADIATION AND COMPOSITIONS COMPRISING SAID ACTIVATED EXTRACT
#64Trypanosome microsome system and uses thereof
#65NOVEL HOMEOPATHIC STRAIN COMPRISING A NOSODE FROM A PROTOZOON OF THE GENUS TRYPANOSOMA
#66Apicomplex vaccine strains of a family of Sarcocystidae
#67Storage stable compositions of biological materials
#68Anti-malaria vaccine
#69Inactivation of genes of the MEP pathway
#70Method for production of arachidonic acid
#71Method for production of arachidonic acid
#72Neutralization of bacterial spores
#73Protozoan strains of reduced virulence and use thereof
#74Method for production of arachidonic acid
#75T. cruzi-derived neurotrophic agents and methods of use therefor
#76Compositions and kits including dehydrated stinging capsules and methods of producing and using same
#77Skin care composition that mediates cell to cell communication